Navigation Links
First patent issues on TAL effector technology
Date:5/13/2013

EVANSTON, Ill., May 13, 2013 /PRNewswire-iReach/ -- The Two Blades Foundation (2Blades), a not-for-profit organization focused on the development and deployment of durable disease resistance for agriculture, announces the April 16th issuance of a key patent for gene editing based on the use of TAL effectors.

TAL effectors are naturally occurring proteins found in plant pathogenic bacteria that contain a novel repeat structure that binds to specific DNA sequences according to a simple cipher or 'code'.  The discovery of this code enables researchers to target proteins to virtually any DNA sequence in a genome with accuracy and ease to delete, add, alter, or regulate genes with high precision.  The TAL code technology was discovered by Ulla Bonas , Jens Boch , Sebastian Schornack , and Thomas Lahaye at Martin-Luther University in Halle, Germany.  It was named Method of the Year in 2011 by the journal Nature Methods and Best Novel Agricultural Technology in the 2012 Informa Agrow Awards.  2Blades has worked with the inventors to develop the technology and a comprehensive estate of patents.  This issued patent, U.S. Pat. No. 8,420,782, is directed to TAL effectors with endonuclease activity.

2Blades has exclusive rights for commercial uses of the technology in plants. Targeted genome modifications in plants are useful to improve agronomic traits, including disease resistance, growth and yield, or tolerance to environmental conditions such as drought. 2Blades has licensed the technology on a non-exclusive basis to a broad range of leading agricultural companies, including Bayer CropScience, DuPont-Pioneer, KWS SAAT AG, Mendel Biotechnology, Monsanto, Simplot, Syngenta Biotechnology and others. "Interest in licensing the technology for food and fuel applications continues t
'/>"/>

SOURCE Two Blades Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update
2. Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results
3. Yongye International Announces First Quarter 2013 Financial Results
4. PDL BioPharma Announces First Quarter 2013 Financial Results
5. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials
6. Celsion Corporation Reports First Quarter 2013 Financial Results and Provides Business Update
7. Vanda Pharmaceuticals Reports First Quarter 2013 Results
8. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
9. Dyadic International To Announce First Quarter 2013 Financial Results And Host Conference Call On Wednesday, May 15, 2013
10. Provitro Biosciences Awarded First-Ever U.S. Patent For Large-Scale Production Of Bamboo Plants
11. Yongye International to Report First Quarter 2013 Financial Results on May 10, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Calcivis, a medical devices ... decay, today announces that it has completed a ... Imaging System. The Calcivis Caries Activity ... consumable combination designed to transform the assessment and ... a unique, proprietary bioluminescence approach combined with a ...
(Date:11/26/2014)... 2014 2014 Deep Research Report ... and in-depth research report on the Ammonium Bifluoride ... definition, classification, application, and industry chain structure as ... international market analysis, including China’s domestic market as ... Asia, China, Japan etc. regions) industry analysis covering ...
(Date:11/26/2014)... , Nov. 26, 2014 Space is one ... of space requires astronauts to maintain consistently high levels ... and prevent potential errors and accidents. Despite the importance ... about how cognition is affected by prolonged spaceflight, and ... Now, Penn Medicine researchers are poised to help the ...
(Date:11/26/2014)... PMG Research, Inc. announced today ... a network of sites that provide clinical research services to ... patient lives through its partnerships with large physician practices and ... site locations in the Southeastern United States and spans over ... board will be held by: Dr. Robert Holmes, ...
Breaking Biology Technology:Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 3Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 2Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 4PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3
... /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, Inc. (OTC Bulletin ... of the leading plasma-based pharmaceutical companies in ... guidance following,the recently announced acquisitions which will ... of plasma based products in China., ...
... AMES, Iowa, Oct. 16 Advanced Analytical Technologies,Inc. (AATI), ... production space,adding an additional 1200 ft2 of space to ... company occupies in Building 4 on the,ISU Research Park ... company will continue to occupy space in 2 building ...
... Radiation Therapy Trials to US ... Patients for First Time, HOUSTON, Oct. 16 The ... they have entered into a,collaboration to increase patient access to ... setting., The collaboration means patients receiving cancer care at ...
Cached Biology Technology:China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million 2China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million 3Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space 2Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials 2Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials 3Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials 4Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials 5
(Date:11/4/2014)... , Nov. 4, 2014   Neurotechnology ... today announced that the latest version of its ... the Ongoing MINEX evaluation organized by ... fingerprint algorithms using the INCITS 378 fingerprint standard ... requirement in public tenders in the ...
(Date:11/3/2014)... A University of Colorado Cancer Center study ... Academy of Sciences describes the activity of a ... Interleukin 37 or IL-37. It has been known to ... in the adaptive immune system: IL-37 inhibits the ability ... antigens. , "Knowing this mechanism that underlies IL-37,s effect ...
(Date:11/3/2014)... birth weight and preterm birth are linked to increased ... published in the American College of Rheumatology (ACR) journal, ... birth weight and pre-term babies were not at greater ... , According to the ACR, 27 million Americans ... OA. Symptoms of OA range from mild to severe ...
Breaking Biology News(10 mins):Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3PNAS: From HIV to cancer, IL-37 regulates immune system 2Preterm, low birth-weight babies may need new hips in adulthood 2
... A University of Oklahoma-led study has demonstrated that ancient ... The microbiomes from ancient people have broad reaching implications ... what good bacteria might have been lost as a ... aseptic practices. Cecil M. Lewis Jr., professor of ...
... cell is like a small city, with factoriescalled organellesdedicated ... functions. A network of intercellular "highways," called microtubules, enables ... about the cell to keep this vital machinery humming. ... Proceedings of the National Academy of Sciences sheds ...
... researchers from across the Asia-Pacific gathered today for the ... Osteoporosis Meeting, taking place at the Kuala Lumpur Convention ... Minister of Health of Malaysia, YB Datuk Rosnah bt. ... than 60 nations. His Excellency Tun Dato, Seri Utama ...
Cached Biology News:OU study suggests the bacterial ecology that lives on humans has changed in the last 100 years 2Study sheds light on how cells transport materials along crowded intercellular 'highways' 2Study sheds light on how cells transport materials along crowded intercellular 'highways' 3IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management 2IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management 3
... Luminescent Detection System is intended for use ... generated by an in-house validated method for ... selected target of interest. • ... is a hybridization capture assay designed to ...
... culture scale-up, these culture chambers produce cell ... 9 range and are useful alternatives ... • High mechanical • strength and structural ... shipping • Certified nonpyrogenic and sterilized by ...
Mouse monoclonal [7B9] to beta II Tubulin ( Abpromise for all tested applications). Antigen: Synthetic peptide, CEEEEGEDEA found at the c-terminus of beta II tubulin. Entrez GeneID: 10383 ...
...
Biology Products: